The US Food and Drug Administration (FDA) will see the biggest cuts, with 19% of jobs in the agency being eliminated.

Soleno Therapeutics has won US Food and Drug Administration (FDA) approval for diazoxide choline – which will be branded as ...

MSD has received approval from the EC for Capvaxive, a pneumococcal 21-valent conjugate vaccine, to prevent invasive disease ...

A total of 29 new blockbuster-in-waiting drugs entered the late-stage pipeline in 2024, a jump from the previous year’s 19.

Ionis has entered a licence agreement with Sobi in which the latter obtains exclusive rights to commercialise olezarsen.

In December 2024, the American Gastroenterological Association (AGA) published an updated clinical guideline for the ...

Bioconjugation presents an new frontier for pharmaceutical development, providing an option for improved drug efficacy across ...

Tribune has secured $39.9m in seed and Series A funding for its therapy portfolio aimed at the central drivers of scar tissue formation.

Multinational companies in China’s vaccine market face headwinds amid an anti-corruption crackdown and rising competition.

The FDA has approved GSK’s Blujepa for treating uncomplicated urinary tract infections (uUTIs) in adult females and ...

EU member states are set to launch the EU Health Data Space Regulation for harmonised data transfer on 26 March.

While Cassava is stopping investigations into simufilam in Alzheimer’s disease, the therapy is now being evaluated in ...